AcelRx Pharmaceuticals Inc./$TLPH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About AcelRx Pharmaceuticals Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Ticker
$TLPH
Sector
Primary listing
Employees
13
Headquarters
Website
TLPH Metrics
BasicAdvanced
$20M
-
-$0.40
-0.10
-
Price and volume
Market cap
$20M
Beta
-0.1
52-week high
$1.20
52-week low
$0.38
Average daily volume
4.9M
Financial strength
Current ratio
2.926
Quick ratio
2.582
Long term debt to equity
98.069
Total debt to equity
98.069
Profitability
Gross margin (TTM)
-22,288.89%
Net profit margin (TTM)
-41,870.37%
Operating margin (TTM)
-49,459.26%
Management effectiveness
Return on assets (TTM)
-40.35%
Return on equity (TTM)
-117.56%
Valuation
Price to revenue (TTM)
1,028.332
Price to book
3.03
Price to tangible book (TTM)
3.03
Price to free cash flow (TTM)
-2.391
Free cash flow yield (TTM)
-41.82%
Free cash flow per share (TTM)
-0.41
Growth
Revenue change (TTM)
-93.22%
Earnings per share change (TTM)
-37.04%
3-year revenue growth (CAGR)
-63.94%
10-year revenue growth (CAGR)
-42.76%
3-year earnings per share growth (CAGR)
-59.13%
10-year earnings per share growth (CAGR)
-31.65%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for AcelRx Pharmaceuticals Inc. stock?
AcelRx Pharmaceuticals Inc. (TLPH) has a market cap of $20M as of September 16, 2025.
What is the P/E ratio for AcelRx Pharmaceuticals Inc. stock?
The price to earnings (P/E) ratio for AcelRx Pharmaceuticals Inc. (TLPH) stock is 0 as of September 16, 2025.
Does AcelRx Pharmaceuticals Inc. stock pay dividends?
No, AcelRx Pharmaceuticals Inc. (TLPH) stock does not pay dividends to its shareholders as of September 16, 2025.
When is the next AcelRx Pharmaceuticals Inc. dividend payment date?
AcelRx Pharmaceuticals Inc. (TLPH) stock does not pay dividends to its shareholders.
What is the beta indicator for AcelRx Pharmaceuticals Inc.?
AcelRx Pharmaceuticals Inc. (TLPH) has a beta rating of -0.1. This means that it has an inverse relation to market volatility.